Thursday, August 29, 2013

Cordlife Group : Solid FY2013, Ready for a Better FY2014 (VR)

Cordlife Group
Invest
Solid FY2013, Ready for a Better FY2014
• Intrinsic Value S$1.40
• Prev Closing Price S$1.215

Cordlife Group Limited’s (Cordlife) FY13 performance was better than expected, with revenue and PAT of S$34.7m and S$13.5m vs estimates of S$31.1m and PAT of S$11.6m. The differences were mainly due to 1) S$3.4m interest income from non-current trade receivables which was reclassified as revenue, 2) one-off gains and losses from the disposal of associate, fair value gain from investment properties, professional fees and others and 3) stronger contribution from its associates.


In all, organic YoY PAT growth (excluding all one-off gain or loss in FY12 and FY13) amount to about 19%, mainly backed by higher client deliveries (increase of 500 to 7,700) and economies of scale. We are also excited about Cordlife’s transitioning from a private cord blood company to a multi-product healthcare company, which may bring about even faster than projected sales growth. We await the disclosure from the company before incorporating the numbers into our model. Recommend Invest with an intrinsic value of S$1.40.

Results Summary: 4Q revenue and gross profit stood at S$10.9m and S$8.9m respectively (up 46% and 69% YoY) mainly due to the change in classification of certain interest income. Excluding that, 4Q revenue was flat YoY at S$7.5m while gross profit climbed 5% YoY to S$5.5m. For FY13, SG&A expenses (excluding one-off expenses) climbed by 20% YoY to S$17m, in line with gross profit growth. There was also a oneoff gain of S$2.9m. Consequently, FY13 PBT rose by 87% YoY to S$14.6m.

Balance sheet remained firmed with S$6.2m of borrowings and cash equivalents and fixed deposits of S$11.5m. There were some substantial changes in trade receivables, trade payables and others mainly due to the consolidation of numbers from the three newly purchased entities. Cash from operating activities rose from S$6.0m to S$8.6m. The company also recommended 1 S cent final dividend.



Source/Extract/Excerpts/来源/转贴/摘录: Voyage-Research,
Publish date: 28/08/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock